CN104397583A - Health instant sweet potato porridge - Google Patents
Health instant sweet potato porridge Download PDFInfo
- Publication number
- CN104397583A CN104397583A CN201410806639.9A CN201410806639A CN104397583A CN 104397583 A CN104397583 A CN 104397583A CN 201410806639 A CN201410806639 A CN 201410806639A CN 104397583 A CN104397583 A CN 104397583A
- Authority
- CN
- China
- Prior art keywords
- instant
- porridge
- different leaf
- sweet potato
- leaf anise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000017020 Ipomoea batatas Species 0.000 title claims abstract description 36
- 235000002678 Ipomoea batatas Nutrition 0.000 title claims abstract description 36
- 235000021395 porridge Nutrition 0.000 title claims abstract description 32
- 230000036541 health Effects 0.000 title abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 12
- 230000008569 process Effects 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 40
- 240000004760 Pimpinella anisum Species 0.000 claims description 40
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 29
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 240000005373 Panax quinquefolius Species 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 23
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 239000012530 fluid Substances 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 230000000259 anti-tumor effect Effects 0.000 abstract description 3
- 230000007812 deficiency Effects 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 241000534059 Pimpinella diversifolia Species 0.000 abstract 4
- 230000001613 neoplastic effect Effects 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 235000021384 green leafy vegetables Nutrition 0.000 abstract 1
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 235000013339 cereals Nutrition 0.000 description 10
- 201000007270 liver cancer Diseases 0.000 description 9
- 208000014018 liver neoplasm Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 244000046052 Phaseolus vulgaris Species 0.000 description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 208000003174 Brain Neoplasms Diseases 0.000 description 4
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 4
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 206010025323 Lymphomas Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 208000020816 lung neoplasm Diseases 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 201000001275 rectum cancer Diseases 0.000 description 4
- 201000000498 stomach carcinoma Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/105—Sweet potatoes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses health instant sweet potato porridge, relates to instant sweet potato porridge for preventing and treating tumors, and provides instant sweet potato porridge for preventing and treating tumors. The health instant sweet potato porridge comprises the following components in parts by weight: 5-10 parts of pimpinella diversifolia fluid extract powder and 50-70 parts of sweet potatoes, wherein the pimpinella diversifolia fluid extract powder is prepared from 100 parts of pimpinella diversifolia by the processes of freezing, drying and crushing into powder after being prepared into the fluid extract; and the instant porridge is prepared from the following raw materials according to the existing technological process of convenient instant porridge. The sweet potatoes have the efficacies of tonifyng deficiency, tonifying qi, strengthening the spleen and stomach, and reinforcing kidney yin; the instant sweet potato porridge for preventing and treating a neoplastic disease is prepared from a civil potherb pimpinella diversifolia, has an antibacterial effect, an antiviral effect and an antitumor effect, and is not only suitable for daily eating and health protection of common customers to prevent the neoplastic disease, but also suitable for auxiliary health protection of patients with tumors.
Description
Technical field
The present invention relates to a kind of Ipomoea batatas instant porridge of anti-curing oncoma, the health-care sweet potato instant porridge of the anti-curing oncoma of especially a kind of adapted Chinese medicine different leaf anise.
Background technology
Moisture containing 60%-80% in Ipomoea batatas block root, the starch of 10%-30%, the sugar of about 5% and a small amount of protein, grease, cellulose, hemicellulose, pectin, ash grade, if be converted into 0.5Kg grain with 2.5Kg fresh sweet potatoes to calculate, in addition to fats, protein, carbohydrate equal size are all high than rice, flour for its nutritional labeling, and in Ipomoea batatas, protein composition is more reasonable, essential amino acids content is high, and the lysine content in Ipomoea batatas particularly comparing shortage in Cereals based food is higher.In addition contain abundant vitamin (carrotene, vitamin A, B, C, E) in Ipomoea batatas, its starch is also easy to be absorbed by the body.Ipomoea batatas is not only healthy food, the good medicine still got rid of illness.Compendium of Material Medica is recorded, effect that Ipomoea batatas has " qi-restoratives is weary, beneficial strength, strengthening the spleen and stomach, strong kidney yin ".Ipomoea batatas is steamed, cuts, shines, receives, and uses grain as, is called potato grain, makes the few disease of people's longevity.Supplementary Amplifications of the Compendium of Materia Medica is said, the bowl spares of Ipomoea batatas energy and blood, warm stomach, fertile the five internal organs.
Prior art does not apply the Ipomoea batatas instant porridge product that different leaf anise prepares anti-curing oncoma, and taste is single, shortage anti-tumor healthcare function.As being the invention of 201310046939.7 in the patent No.---the processing method of the instant porridge that a kind of cereal and starchiness beans are arranged in pairs or groups, the processing method of the instant porridge that a kind of cereal of this disclosure of the invention and starchiness beans are arranged in pairs or groups, grain dust and starchiness beans powder are carried out pretreatment, by an extruded αization, low temperature drying and high temperature secondary αization, the instant porridge that cereal and starchiness beans are arranged in pairs or groups can be obtained; Instant porridge moisture prepared by the method is below 10%, and α degree is more than 95%; This invention process serialization degree is high, and the instant porridge rehydration effect that the cereal produced and starchiness beans are arranged in pairs or groups is good, can in 3 ~ 4min rehydration under brewed in hot water, maintains cereal and the distinctive nutrition of starchiness beans and amino acid balance.
Summary of the invention
In order to solve prior art problem, the object of the invention is the Ipomoea batatas instant porridge that will provide a kind of anti-curing oncoma, be not only applicable to the daily edible health of ordinary consumer to prevent tumor disease, the treatment for the tumor patient state of an illness also plays health care booster action.
Technical scheme: a kind of Ipomoea batatas instant porridge of anti-curing oncoma, composition of filling a prescription by weight comprises different leaf anise liquid extract dry powder 5-10 part, Ipomoea batatas 50-70 part; Described different leaf anise liquid extract dry powder is that after making liquid extract with different leaf anise 100 weight portion, freeze drying is ground into dry powder again; Above raw material is made instant porridge by the technological process of existing convenient instant congee.
Experimental study: confirm that different leaf anise Chinese medicine liquid extract has obvious tumor-inhibiting action to rat liver cancer (H22) animal liver cancer model; Different leaf anise Chinese medicine liquid extract has the effect strengthening mouse cell immunity and humoral immune function, and to K562 and the A549 cell cycle, there is retardation, apoptotic effect is promoted to K562 and HepG2 cell, in protein level and mRNA level in-site are to K562 cell, short apoptogene BAX all has rise effect, to the expression of K562 cell and HepG2 cell proliferation and telomerase gene, there is remarkable inhibitory action, show that different leaf anise has obvious antitumor action thus.
Experimental technique
:different leaf anise liquid extract makes different leaf anise liquid extract with different leaf anise by Chinese medicine liquid extract method for making.Set up rat liver cancer (H22) zoografting tumor model, random mouse is divided into normal group, model group, positive group, medicine is little, in, heavy dose of group and administration respectively, after experiment terminates, carry out the indexs of correlation such as tumour inhibiting rate, thymus index, spleen index, tumor tissue pathology to detect, result: the tumor growth of different leaf anise liquid extract to tumor-bearing mice has obvious inhibitory action, the tumour inhibiting rate of basic, normal, high dosage group is respectively 31.08%, 42.36% and 46.20%, presents good dose-effect relationship.Pathological observation shows, and model group growth of tumour cell is vigorous, and tumor cell necrosis in various degree then appears in each medication group, conclusion: different leaf anise liquid extract has obvious tumor-inhibiting action to rat liver cancer (H22) animal liver cancer model.
Different leaf anise is tested by " food safety evaluation on toxicology test " in " health food inspection and assessment technical specification " (2003 editions), result shows acute toxicity test its mouse oral LD50 > 20g/kg, true border is nontoxic, long_term toxcity result of study confirms: the rat feeding trial on the 30th of different leaf anise, have no experimental animal and occur poisoning symptom, gross anatomy and structure observation no abnormality seen pathological change.Rat body weight, food-intake, food utilization, blood picture, blood biochemistry are all had no significant effect.Different leaf anise high dose group dosage that is female, buck is human body RD (60mg/kg BW/d) 120 times.Confirm that Chinese herbal medicine different leaf anise long-term taking is safety non-toxic.
Clinical verification, point experimental group and control group: after experimental group adopts different leaf anise liquid extract of the present invention to treat three courses for the treatment of (90 days), compared with treating after three courses for the treatment of with control group (employing chemotherapy and radiation), the total effective rate adopting the experimental group Advanced cancers treatment of different leaf anise liquid extract treatment of the present invention is 94.2%, control group is 65.8% to the total effective rate that Advanced cancers is treated, and the total effective rate for the treatment of group is apparently higher than control group.
1, case selection: select case 240 example meeting Advanced cancers diagnostic criteria, patient is divided into two groups at random, treatment group 120 example, wherein male 66 examples (liver cancer 16 example, lung cancer 14 example, cancer of the stomach 13 example, cancer of the esophagus 9 example, brain tumor 6 example, the carcinoma of the rectum 3 example, malignant lymphoma 5 example), female 54 example (liver cancer 10 example, lung cancer 10 example, cancer of the stomach 10 example, cancer of the esophagus 8 example, brain tumor 5 example, the carcinoma of the rectum 6 example, malignant lymphoma 5 example); 22 ~ 78 years old age, 50.1 years old mean age; The course of disease 3 ~ 18 months, average 9.2 months.Control group 120 example, wherein male 64 examples (liver cancer 11 example, lung cancer 17 example, cancer of the stomach 10, the carcinoma of the rectum 8 example, carcinoma of urinary bladder 6 example, cancer of the esophagus 6 example, brain tumor 3 example, malignant lymphoma 3 example), female 56 example (liver cancer 9 example, lung cancer 10 example, cancer of the stomach 9 example, the carcinoma of the rectum 5 example, cancer of the esophagus 6 example, brain tumor 3 example, breast cancer 4 example, cervical carcinoma 3 example, oophoroma 3 example, malignant lymphoma 4 example); 25 ~ 80 years old age, 51.3 years old mean age; The course of disease 3 ~ 18 months, average 8.9 months.Two groups of qualifications and record of service are basically identical, and there was no significant difference, has comparativity.
2, treatment group patient takes different leaf anise liquid extract of the present invention, an oral 10-15 milliliter of being grown up, and 3 times on the one 30 days is a course for the treatment of; Take 90 days continuously.Control group adopts chemotherapy and radiation.
3, criterion: effective: tumour knurl body reduces more than 5%, and subjective symptoms is obviously improved, cardinal symptom disappears; Effective: tumour knurl body reduces 2 ~ 5%, and clinical symptoms are obviously improved; Improve: tumour knurl body maintains original size, clinical symptoms are improved; Invalid: tumour knurl body continuation growth and clinical symptoms are without improvement or increase the weight of.
4, result: take in treatment group of the present invention, effective: 63 examples, effective 30 examples, improve 20 examples, invalid 7 examples, total effective rate 94.2%; Effective 45 examples in control group, effective 23 examples, improve 10 examples, invalid 42 examples, total effective rate 65.0%; The total effective rate for the treatment of group is apparently higher than control group.
As optimization, the Ipomoea batatas instant porridge of a kind of anti-curing oncoma of the present invention, composition of filling a prescription by weight comprises different leaf anise liquid extract dry powder 5-10 part, Ipomoea batatas 50-70 part, rice 10-20 part, sugared 5-10 part; Described different leaf anise liquid extract dry powder be with different leaf anise 100 parts, rush 0.2-2 part, Radix Astragali 5-10 part, American Ginseng 5-10 part after making liquid extract again freeze drying be ground into dry powder; Above raw material is made instant porridge by the technological process of existing convenient instant congee.
Pungent, bitter, micro-sweet, the slightly warm in nature of different leaf anise taste; Return lung; Stomach, Liver Channel.Function cures mainly: loose wind declares lung, regulating qi-flowing for relieving pain, disappear long-pending invigorating the spleen, activating blood to promote menstruation, removing dampness and detoxicating.Main flu, cough, pertussis, tuberculosis, lung carbuncle, headache, headache, bud pain, crisp hypochondriac pain, peratodynia, abdominal distention and pain, koro crymodynia, rheumatic arthritis, internal lesion caused by overexertion, bone labor, indigestion, dyspepsia, infantile malnutrition due to digestive disturbances or intestinalparasites, acute filthy disease, rush down dysentery, jaundice, malaria, irregular menstruation, dysmenorrhoea, through closing, swollen, the order screen of breast, pharynx swollen, mumps, traumatic injury, eczema, pruitus, snakeworm wound.
Rush, is slightly cold, sweet, light; The thoughts of returning home, lung, small intestine, urinary bladder channel.Effect: promoting diuresis for stranguria, clearing heart fire.
Radix Astragali taste is sweet, warm, the thoughts of returning home, lung, spleen, kidney channel; Function cures mainly: invigorating qi for strengthening superficies, diuresis, pus draining and toxin expelling, regenerating tissue to heal wond.Cure mainly palpitaition of breathing hard, burnout, weak, spontaneous perspiration, night sweat, rush down for a long time, impractical swollen, chronic nephritis, the ulcer difficulty of prolapse of the anus, the prolapse of uterus, body bursts or burst and do not hold back for a long time.The Radix Astragali has enhanced machine body immunity function, protects the liver, diuresis, anti-ageing, resisting stress, step-down and antibacterial action more widely.Jishengshenqiwan albuminuria can be eliminated, strengthen myocardial contractive power, regulate blood-sugar content.The Radix Astragali can not only coronary artery dilator, improves myocardial blood supply, improves immunologic function, and can the process of delaying cell aging.Radix Astragali instant, can decoct soup, soft extracts, infusing drugs in wine, enter dish etc.
Sweet, the micro-hardship of American Ginseng taste, cool.The thoughts of returning home, lung, kidney channel.Function cures mainly: boosting qi and nourishing yin, clearing heat and promoting fluid.For the deficiency of vital energy the moon lose, interior heat, cough breathe heavily phlegm blood, abnormal heat be tired of tired, quench one's thirst, dryness of the mouth and throat.
Advantage of the present invention is: 1, the pure and fresh glycol of taste, adds the novel taste of instant porridge.Select the different leaf anise of natural Chinese medicinal herb to be raw material, use safety, utilize Chinese herbal medicine integrated control tumour, without obvious toxic-side effects; Experiment proves that different leaf anise single medicinal material liquid extract has anti-bacteria and anti-virus, cancer suppressing action; There is the immunologic function removed carcinous toxin, improve body against cancer.
2, preferably side with the removing toxic substances of different leaf anise removing damp-heat, regulating qi-flowing for relieving pain, disappear long-pending invigorating the spleen, activating blood to promote menstruation; Loose wind a surname lung; Improve effect of immunologic function, compatibility rush promoting diuresis for stranguria, clearing heart fire, Radix Astragali invigorating qi and benefiting blood, warming yang for diuresis, the effects such as removing toxic substances of calming the nerves, and American Ginseng supplement vigour, benefit strengthening spleen and lung, nourishing generate fluid, calm the nerves nourish heart, brain-tonifying effect.
3, Ipomoea batatas has effect of weary, the beneficial strength of qi-restoratives, strengthening the spleen and stomach, strong kidney yin; The present invention utilizes the different leaf anise of edible wild herbs among the people to make the Ipomoea batatas instant porridge of control tumor disease, has anti-bacteria and anti-virus, cancer suppressing action; Be not only applicable to the daily edible health of ordinary consumer to prevent tumor disease, be applicable to the health-care assistance of tumor patient yet.
Detailed description of the invention
Embodiment 1: a kind of Ipomoea batatas instant porridge of anti-curing oncoma, composition of filling a prescription by weight comprises different leaf anise liquid extract dry powder 5-10 part, Ipomoea batatas 50-70 part; Described different leaf anise liquid extract dry powder is that after making liquid extract with different leaf anise 100 weight portion, freeze drying is ground into dry powder again; Above raw material is made instant porridge by the technological process of existing convenient instant congee.
Embodiment 2: a kind of Ipomoea batatas instant porridge of anti-curing oncoma, composition of filling a prescription by weight comprises different leaf anise liquid extract dry powder 5-10 part, Ipomoea batatas 50-70 part, rice 10-20 part, sugared 5-10 part; Described different leaf anise liquid extract dry powder be with different leaf anise 100 parts, rush 0.2-2 part, Radix Astragali 5-10 part, American Ginseng 5-10 part after making liquid extract again freeze drying be ground into dry powder; Above raw material is made instant porridge by the technological process of existing convenient instant congee.
Claims (2)
1. an Ipomoea batatas instant porridge for anti-curing oncoma, composition of filling a prescription by weight comprises different leaf anise liquid extract dry powder 5-10 part, Ipomoea batatas 50-70 part; Described different leaf anise liquid extract dry powder is that after making liquid extract with different leaf anise 100 weight portion, freeze drying is ground into dry powder again; Above raw material is made instant porridge by the technological process of existing convenient instant congee.
2. an Ipomoea batatas instant porridge for anti-curing oncoma, composition of filling a prescription by weight comprises different leaf anise liquid extract dry powder 5-10 part, Ipomoea batatas 50-70 part, rice 10-20 part, rice 10-20 part, sugared 5-10 part; Described different leaf anise liquid extract dry powder be with different leaf anise 100 parts, rush 0.2-2 part, Radix Astragali 5-10 part, American Ginseng 5-10 part after making liquid extract again freeze drying be ground into dry powder; Above raw material is made instant porridge by the technological process of existing convenient instant congee.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410806639.9A CN104397583A (en) | 2014-12-23 | 2014-12-23 | Health instant sweet potato porridge |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410806639.9A CN104397583A (en) | 2014-12-23 | 2014-12-23 | Health instant sweet potato porridge |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104397583A true CN104397583A (en) | 2015-03-11 |
Family
ID=52635305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410806639.9A Pending CN104397583A (en) | 2014-12-23 | 2014-12-23 | Health instant sweet potato porridge |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104397583A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1954840A (en) * | 2005-10-26 | 2007-05-02 | 黄振华 | Medical composite prepared by Gynostemma pentaphylla, American ginseng and astragalus root |
| CN102178796A (en) * | 2011-04-29 | 2011-09-14 | 苏州中药研究所 | Application of effective component of medulla Junci in preparing medicine, health food or cosmetic for resisting tumor or inhibiting angiogenesis |
| CN102669331A (en) * | 2012-05-09 | 2012-09-19 | 胡贡堂 | Pimpinella diversifolia healthcare tea |
| CN103461910A (en) * | 2013-08-15 | 2013-12-25 | 陈瑞 | Anticancer health preserving sweet potato maize gruel and making method thereof |
| CN103518919A (en) * | 2013-10-30 | 2014-01-22 | 杨小燕 | Coffee |
| CN103621649A (en) * | 2013-12-22 | 2014-03-12 | 罗世灼 | Healthcare soymilk |
-
2014
- 2014-12-23 CN CN201410806639.9A patent/CN104397583A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1954840A (en) * | 2005-10-26 | 2007-05-02 | 黄振华 | Medical composite prepared by Gynostemma pentaphylla, American ginseng and astragalus root |
| CN102178796A (en) * | 2011-04-29 | 2011-09-14 | 苏州中药研究所 | Application of effective component of medulla Junci in preparing medicine, health food or cosmetic for resisting tumor or inhibiting angiogenesis |
| CN102669331A (en) * | 2012-05-09 | 2012-09-19 | 胡贡堂 | Pimpinella diversifolia healthcare tea |
| CN103461910A (en) * | 2013-08-15 | 2013-12-25 | 陈瑞 | Anticancer health preserving sweet potato maize gruel and making method thereof |
| CN103518919A (en) * | 2013-10-30 | 2014-01-22 | 杨小燕 | Coffee |
| CN103621649A (en) * | 2013-12-22 | 2014-03-12 | 罗世灼 | Healthcare soymilk |
Non-Patent Citations (2)
| Title |
|---|
| 徐晓卫等: "浙江产异叶茴芹叶挥发油化学成分研究", 《中国药业》 * |
| 犀文: "《四季营养餐1688例》", 31 May 2012, 浙江科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104543714A (en) | Health instant potato porridge | |
| CN104432239A (en) | Sturgeon ball food | |
| CN104397749A (en) | Quail sausage for preventing and treating tumors | |
| CN104473054A (en) | Instant rice porridge with tumor prevention and treatment functions | |
| CN104397583A (en) | Health instant sweet potato porridge | |
| CN104430775A (en) | Health cake preventing and treating tumors | |
| CN104489034A (en) | Health care biscuit with tumor preventing and treating function | |
| CN104522709A (en) | Duck sausage for preventing and treating tumor | |
| CN104585793A (en) | Tilapia ball food | |
| CN104473235A (en) | Health-care eel ball food | |
| CN104522733A (en) | Giant salamander ball food | |
| CN105767747A (en) | Crocodile ball food | |
| CN104522746A (en) | Lobster sausage for preventing and treating tumor | |
| CN104489769A (en) | Snakehead fish ball food | |
| CN104489773A (en) | Health grass carp ball food | |
| CN104397756A (en) | Health sausages containing bullfrog meat | |
| CN104473053A (en) | Instant red bean porridge with tumor prevention and treatment functions | |
| CN104431797A (en) | Sorghum instant gruel capable of preventing and treating tumours | |
| CN104473055A (en) | Instant millet porridge with tumor prevention and treatment functions | |
| CN104522503A (en) | Instant oat porridge for preventing and treating tumor | |
| CN104431798A (en) | Corn instant gruel capable of preventing and treating tumours | |
| CN104473082A (en) | Instant bamboo bean porridge with tumor prevention and treatment functions | |
| CN104543715A (en) | Buckwheat instant porridge for preventing and treating tumors | |
| CN104472626A (en) | Tumor-preventing health bread | |
| CN104430892A (en) | Health mare milk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150311 |